# KCNT2

## Overview
The KCNT2 gene encodes the potassium sodium-activated channel subfamily T member 2, commonly referred to as the Slick channel. This protein is a transmembrane ion channel that plays a pivotal role in regulating neuronal excitability by controlling the flow of potassium ions in response to sodium and ATP levels. Structurally, the Slick channel is characterized by six transmembrane segments and a pore-lining loop, forming a tetrameric assembly that is sensitive to intracellular ATP and chloride levels (Ambrosino2018De; Jackson2021Recurrent). Functionally, it is involved in maintaining the resting membrane potential and modulating action potentials, primarily in the brain, where it influences cognitive and motor functions (Kaczmarek2013Slack; Mao2020The). Mutations in KCNT2 have been linked to various neurological disorders, including developmental and epileptic encephalopathies, highlighting its clinical significance (Inuzuka2020Additional; Gong2021Case).

## Structure
The KCNT2 gene encodes a potassium channel protein known as Slick, which is part of the sodium-activated potassium channel family. The protein structure includes six transmembrane segments (S1-S6) and a pore-lining loop between S5 and S6, resembling the structure of Kv channels (Ambrosino2018De; Jackson2021Recurrent). The channel subunits assemble as tetramers to form a functional channel, indicating a quaternary structure (Jackson2021Recurrent).

The protein has cytosolic N- and C-termini, with the C-terminus containing two regulators of conductance of K+ (RCK) domains that form an intracellular gating ring, conferring ligand-dependent sensitivity to the channel's opening process (Ambrosino2018De). The Slick channel is characterized by rapid gating kinetics and sensitivity to intracellular ATP levels, which distinguishes it from the Slack channel (Cui2024Identification).

The KCNT2 protein also features a consensus ATP binding site just C-terminal to the second RCK domain, making it sensitive to cytoplasmic ATP levels, which reduces channel activity (Kaczmarek2013Slack). Variants in the KCNT2 gene can lead to either gain-of-function or loss-of-function effects, affecting the channel's function and contributing to conditions such as developmental and epileptic encephalopathies (Cui2024Identification).

## Function
The KCNT2 gene encodes the Slick channel, a sodium-activated potassium (KNa) channel that plays a crucial role in regulating neuronal excitability and firing patterns. These channels are involved in maintaining the resting membrane potential and modulating action potentials in neurons by controlling the flow of potassium ions across the cell membrane. Slick channels activate rapidly upon depolarization and exhibit multiple subconductance states, contributing to the modulation of neuronal excitability in response to changes in sodium, chloride, and ATP levels (Kaczmarek2013Slack).

Slick channels are unique in their ability to maintain a basal level of activity even in the absence of sodium, unlike their closely related Slack channels. They are more sensitive to intracellular chloride levels and contain a consensus ATP binding site, which makes their activity sensitive to cytoplasmic ATP levels (Kaczmarek2013Slack). These channels are primarily active in the brain, where they contribute to normal cognitive and motor functions by influencing processes such as neurotransmitter release and synaptic plasticity (Mao2020The).

The transcription of the KCNT2 gene is regulated by nuclear factor-κB (NFκB), which plays a role in neuronal plasticity and neuroprotection, particularly during ischemic conditions (Tomasello2015Transcriptional).

## Clinical Significance
Mutations in the KCNT2 gene are associated with a range of developmental and epileptic encephalopathies (DEEs), which are severe neurological disorders characterized by early-onset epilepsy, developmental delay, and intellectual disability. Specific conditions linked to KCNT2 mutations include Early Infantile Epileptic Encephalopathy 57 (EIEE57), Ohtahara syndrome, and epilepsy of infancy with migrating focal seizures (EIMFS) (Inuzuka2020Additional; Mao2020The; Gong2021Case). 

KCNT2 mutations can result in both gain-of-function and loss-of-function effects on the sodium-activated potassium channels, leading to altered neuronal excitability and signaling. For instance, the Phe240Leu mutation alters ion selectivity, contributing to membrane hyperexcitability and epileptic encephalopathy (Gururaj2017A). Other mutations, such as those affecting the Arg190 residue, have been linked to intellectual disability and dysmorphic features, although not always accompanied by epilepsy (Jackson2021Recurrent).

The clinical manifestations of KCNT2-related disorders often overlap with those of KCNT1-related conditions, and they may include distinctive facial features and hypertrichosis (Cui2024Identification). Treatment strategies focus on symptomatic management, with emerging therapies like potassium channel blockers showing potential in improving outcomes (Ambrosino2018De).

## Interactions
KCNT2, also known as the potassium sodium-activated channel subfamily T member 2, is involved in several protein-protein interactions that influence its function and localization. KCNT2 forms heteromeric sodium-activated potassium (KNa) channels by coassembling with the Slick subunit, encoded by the Slo2.1 gene. This interaction is crucial for the formation and trafficking of these channels to the plasma membrane, with the N-terminal domain of the Slack-B variant playing a significant role in this process (Chen2009The).

In the mouse brain, KCNT2 interacts with several proteins, including beta-synuclein, TMEM 263, DPP 10, and SAP 102. These interactions were identified through co-immunoprecipitation and mass spectrometric sequencing. Beta-synuclein and TMEM 263 are potential novel interaction partners, while DPP 10 and SAP 102 are components of the native KCNT2 channel complexes. These interactions may influence the molecular properties and functional diversity of KCNT2 channels (Rizzi2015Identification).

KCNT2 also interacts with the Fragile X Mental Retardation Protein (FMRP), which is known to regulate neuronal excitability. FMRP binds to the cytoplasmic C-terminus of KCNT2, enhancing channel activity and influencing protein translation regulation (Kaczmarek2013Slack).


## References


[1. (Cui2024Identification) Fengji Cui, Tuoya Wulan, Qian Zhang, Victor Wei Zhang, and Yuhua Jiang. Identification of a novel kcnt2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review. Frontiers in Genetics, March 2024. URL: http://dx.doi.org/10.3389/fgene.2024.1371282, doi:10.3389/fgene.2024.1371282. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2024.1371282)

[2. (Chen2009The) Haijun Chen, Jack Kronengold, Yangyang Yan, Valeswara-Rao Gazula, Maile R. Brown, Liqun Ma, Gonzalo Ferreira, Youshan Yang, Arin Bhattacharjee, Fred J. Sigworth, Larry Salkoff, and Leonard K. Kaczmarek. The n-terminal domain of slack determines the formation and trafficking of slick/slack heteromeric sodium-activated potassium channels. The Journal of Neuroscience, 29(17):5654–5665, April 2009. URL: http://dx.doi.org/10.1523/jneurosci.5978-08.2009, doi:10.1523/jneurosci.5978-08.2009. This article has 75 citations.](https://doi.org/10.1523/jneurosci.5978-08.2009)

[3. (Jackson2021Recurrent) Adam Jackson, Siddharth Banka, Helen Stewart, Hannah Robinson, Simon Lovell, and Jill Clayton‐Smith. Recurrent <scp>kcnt2</scp> missense variants affecting p.arg190 result in a recognizable phenotype. American Journal of Medical Genetics Part A, 185(10):3083–3091, June 2021. URL: http://dx.doi.org/10.1002/ajmg.a.62370, doi:10.1002/ajmg.a.62370. This article has 8 citations.](https://doi.org/10.1002/ajmg.a.62370)

[4. (Gong2021Case) Pan Gong, Xianru Jiao, Dan Yu, and Zhixian Yang. Case report: causative de novo variants of kcnt2 for developmental and epileptic encephalopathy. Frontiers in Genetics, June 2021. URL: http://dx.doi.org/10.3389/fgene.2021.649556, doi:10.3389/fgene.2021.649556. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.649556)

[5. (Ambrosino2018De) Paolo Ambrosino, Maria Virginia Soldovieri, Thomas Bast, Peter D. Turnpenny, Sabine Uhrig, Saskia Biskup, Miriam Döcker, Thilo Fleck, Ilaria Mosca, Laura Manocchio, Nunzio Iraci, Maurizio Taglialatela, and Johannes R. Lemke. De novo gain‐of‐function variants in kcnt2 as a novel cause of developmental and epileptic encephalopathy. Annals of Neurology, 83(6):1198–1204, June 2018. URL: http://dx.doi.org/10.1002/ana.25248, doi:10.1002/ana.25248. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.25248)

[6. (Gururaj2017A) Sushmitha Gururaj, Elizabeth Emma Palmer, Garrett D. Sheehan, Tejaswi Kandula, Rebecca Macintosh, Kevin Ying, Paula Morris, Jiang Tao, Kerith-Rae Dias, Ying Zhu, Marcel E. Dinger, Mark J. Cowley, Edwin P. Kirk, Tony Roscioli, Rani Sachdev, Michael E. Duffey, Ann Bye, and Arin Bhattacharjee. A de novo mutation in the sodium-activated potassium channel kcnt2 alters ion selectivity and causes epileptic encephalopathy. Cell Reports, 21(4):926–933, October 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.09.088, doi:10.1016/j.celrep.2017.09.088. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.09.088)

[7. (Kaczmarek2013Slack) Leonard K. Kaczmarek. Slack, slick, and sodium-activated potassium channels. ISRN Neuroscience, 2013:1–14, May 2013. URL: http://dx.doi.org/10.1155/2013/354262, doi:10.1155/2013/354262. This article has 105 citations.](https://doi.org/10.1155/2013/354262)

[8. (Rizzi2015Identification) Sandra Rizzi, Christoph Schwarzer, Leopold Kremser, Herbert H. Lindner, and Hans-Günther Knaus. Identification of potential novel interaction partners of the sodium-activated potassium channels slick and slack in mouse brain. Biochemistry and Biophysics Reports, 4:291–298, December 2015. URL: http://dx.doi.org/10.1016/j.bbrep.2015.09.024, doi:10.1016/j.bbrep.2015.09.024. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrep.2015.09.024)

[9. (Inuzuka2020Additional) Luciana Midori Inuzuka, Lucia Inês Macedo-Souza, Bruno Della-Ripa, Fabiola Paoli Monteiro, Luiza Ramos, João Paulo Kitajima, Eliana Garzon, and Fernando Kok. Additional observation of a de novo pathogenic variant in kcnt2 leading to epileptic encephalopathy with clinical features of frontal lobe epilepsy. Brain and Development, 42(9):691–695, October 2020. URL: http://dx.doi.org/10.1016/j.braindev.2020.05.003, doi:10.1016/j.braindev.2020.05.003. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.braindev.2020.05.003)

[10. (Mao2020The) Xiao Mao, Nadine Bruneau, Quwen Gao, Hélène Becq, Zhengjun Jia, Hui Xi, Li Shu, Hua Wang, Pierre Szepetowski, and Laurent Aniksztejn. The epilepsy of infancy with migrating focal seizures: identification of de novo mutations of the kcnt2 gene that exert inhibitory effects on the corresponding heteromeric kna1.1/kna1.2 potassium channel. Frontiers in Cellular Neuroscience, January 2020. URL: http://dx.doi.org/10.3389/fncel.2020.00001, doi:10.3389/fncel.2020.00001. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2020.00001)

[11. (Tomasello2015Transcriptional) Danielle L. Tomasello, Amy M. Gancarz-Kausch, David M. Dietz, and Arin Bhattacharjee. Transcriptional regulation of the sodium-activated potassium channel slick (kcnt2) promoter by nuclear factor-κb. Journal of Biological Chemistry, 290(30):18575–18583, July 2015. URL: http://dx.doi.org/10.1074/jbc.M115.643536, doi:10.1074/jbc.m115.643536. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M115.643536)